Kavar Capital Partners Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$270K Buy
2,948
+136
+5% +$11.9K 0.03% 177
2026
Q1
$240K Hold
2,812
0.03% 192
2025
Q4
$222K Buy
2,812
+12
+0.4% +$941 0.03% 174
2025
Q3
$224K Hold
2,800
0.03% 169
2025
Q2
$255K Hold
2,800
0.04% 171
2025
Q1
$262K Hold
2,800
0.04% 152
2024
Q4
$255K Hold
2,800
0.04% 150
2024
Q3
$291K Hold
2,800
0.05% 146
2024
Q2
$272K Sell
2,800
-217
-7% -$20K 0.05% 141
2024
Q1
$272K Sell
3,017
-3,017
-50% -$256K 0.05% 138
2023
Q4
$481K Buy
6,034
+3,017
+100% +$227K 0.05% 132
2023
Q3
$215K Sell
3,017
-190
-6% -$14.2K 0.05% 148
2023
Q2
$247K Sell
3,207
-55
-2% -$4.26K 0.05% 126
2023
Q1
$245K Sell
3,262
-40
-1% -$2.97K 0.05% 137
2022
Q4
$260K Sell
3,302
-215
-6% -$16.1K 0.06% 125
2022
Q3
$247K Hold
3,517
0.06% 127
2022
Q2
$282K Sell
3,517
-150
-4% -$11.7K 0.07% 143
2022
Q1
$278K Hold
3,667
0.06% 133
2021
Q4
$313K Hold
3,667
0.07% 136
2021
Q3
$277K Hold
3,667
0.06% 147
2021
Q2
$298K Hold
3,667
0.07% 131
2021
Q1
$289K Buy
+3,667
New +$287K 0.08% 121
2020
Q3
Sell
-3,471
Closed -$254K 145
2020
Q2
$254K Hold
3,471
0.1% 110
2020
Q1
$230K Buy
+3,471
New +$245K 0.11% 104
2019
Q3
Sell
-1,929
Closed -$138K 188
2019
Q2
$138K Buy
+1,929
New +$137K 0.05% 147
2018
Q3
Sell
-2,079
Closed -$135K 148
2018
Q2
$135K Hold
2,079
0.07% 127
2018
Q1
$149K Buy
+2,079
New +$150K 0.08% 122
2016
Q1
Sell
-2,400
Closed -$159K 142
2015
Q4
$159K Hold
2,400
0.1% 110
2015
Q3
$152K Buy
2,400
+400
+20% +$26.1K 0.11% 114
2015
Q2
$130K Buy
+2,000
New +$136K 0.09% 131
2014
Q2
Sell
-2,270
Closed -$147K 178
2014
Q1
$147K Hold
2,270
0.12% 141
2013
Q4
$148K Buy
+2,270
New +$145K 0.13% 128

Other funds holding CL

Kavar Capital Partners Group's CL Position: Q2 2026 in Review

Kavar Capital Partners Group increased its Colgate-Palmolive (CL) stake by 4.8% in Q2 2026, buying an estimated $11.9K and bringing the position to 2,948 shares worth $270K. The position accounts for 0.03% of the portfolio, ranked #177.

Kavar Capital Partners Group first reported a position in CL in Q4 2013 and has held it in 32 quarters since. The position peaked at $481K in Q4 2023. 624 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Kavar Capital Partners Group held 2,948 shares of Colgate-Palmolive worth $270K as of Q2 2026.
  • Kavar Capital Partners Group bought 136 Colgate-Palmolive shares in Q2 2026, an estimated $11.9K.
  • Colgate-Palmolive made up 0.03% of Kavar Capital Partners Group's portfolio in Q2 2026, its #177 holding.
  • Kavar Capital Partners Group first reported a position in Colgate-Palmolive in Q4 2013 and has held it in 32 quarters since.
  • Kavar Capital Partners Group's Colgate-Palmolive position peaked at $481K in Q4 2023.
  • 624 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Kavar Capital Partners Group's 13F filing for Q2 2026, filed 20 Jul 2026.